ferroquine
Small moleculeexperimental
Clinical trial activity
6 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
5
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2007 (NCT00563914)
Timeline
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ferroquine
- ferroquine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05911828 | Phase 1 | Jul 1, 2023 | Zydus Discovery DMCC |
| NCT03660839 | Phase 2 | Sep 5, 2018 | Sanofi |
| NCT04264130 | Phase 2 | Jul 31, 2018 | Centre de Recherche Médicale de Lambaréné |
| NCT02497612 | Phase 2 | Jul 25, 2015 | Sanofi |
| NCT00988507 | Phase 2 | Oct 1, 2009 | Sanofi |
| NCT00563914 | Phase 1/Phase 2 (Phase 2) | Oct 1, 2007 | Sanofi |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Sanofi | For profit | 4 | 4 | 1 | 2007 |
| Centre de Recherche Médicale de Lambaréné | Academic/Hospital | 1 | 1 | 1 | 2018 |
| Zydus Discovery DMCC | For profit | 1 | 1 | 1 | 2023 |
3 organizations
Page 1 / 1